Pfizer
PFE
PFE
2,057 hedge funds and large institutions have $140B invested in Pfizer in 2016 Q4 according to their latest regulatory filings, with 193 funds opening new positions, 869 increasing their positions, 797 reducing their positions, and 64 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
3% less capital invested
Capital invested by funds: $144B → $140B (-$4.35B)
17% less call options, than puts
Call options by funds: $2.07B | Put options by funds: $2.49B
26% less funds holding in top 10
Funds holding in top 10: 234 → 172 (-62)
Holders
2,057
Holding in Top 10
172
Calls
$2.07B
Puts
$2.49B
Top Buyers
| 1 | +$550M | |
| 2 | +$351M | |
| 3 | +$349M | |
| 4 |
Asset Management One
Tokyo,
Japan
|
+$296M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$283M |
Top Sellers
| 1 | -$1.63B | |
| 2 | -$400M | |
| 3 | -$338M | |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$288M |
| 5 |
Bank of New York Mellon
New York
|
-$209M |